EGFR and neoplasm: Wei et al. (2014) have demonstrated that the EGFR mutation ratio showed a high level of concordance in primary tumors and when the tumor content is more than 50% in a tumor sample, a randomly chosen sample would reliably represent the type and ratio of mutations of EGFR in primary tumors.